Academic Journal
Q1Drug Resistance Updates
Q1Ranking
15.8Impact Factor
148H-index
5.279SJR
2.1Research Score
1998-2026Coverage
About Drug Resistance Updates
Drug Resistance Updates is a scholarly journal published by Churchill Livingstone. SCImago 2025 places it in Q1 with an SJR of 5.279 and an H-index of 148.
Its listed coverage is 1998-2026 and its research categories include Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1). The 2025 dataset reports 90 documents and 4287 citations across the latest three-year reporting window.
Drug Resistance Updates: A Leading Journal in Combating Drug Resistance
Drug Resistance Updates is a premier, peer-reviewed journal published bimonthly by Elsevier. It serves as a critical resource for researchers, clinicians, and healthcare professionals dedicated to understanding and overcoming drug resistance in infectious diseases and cancer. The journal offers comprehensive reviews, original research, and expert commentaries that bridge basic science and clinical practice.
Scope and Focus
The journal covers a broad spectrum of topics related to drug resistance, including:- Molecular biology and biochemistry
- Cell biology and pharmacology
- Microbiology and oncology
- Preclinical therapeutics and clinical medicine
Editorial Excellence
Under the leadership of Editor-in-Chief Dr. Zhe-Sheng Chen from St. John's University, New York, the journal maintains rigorous peer-review standards. Articles are typically invited and authored by leading experts in the field, ensuring high-quality and authoritative content citeturn0search0.Impact and Recognition
Drug Resistance Updates boasts impressive metrics that reflect its influence in the scientific community:- Impact Factor: 15.8 (2023)
- CiteScore: 26.2
- h-index: 132
- SCImago Journal Rank (SJR): 4.665
Timely and Efficient Publication
Committed to rapid dissemination of research, the journal offers:- Time to First Decision: Approximately 3 days
- Review Time: Around 51 days
- Submission to Acceptance: Approximately 90 days
Open Access and Accessibility
While Drug Resistance Updates primarily operates on a subscription model, it supports open access publishing. Authors can opt for open access with an article processing charge of $5,410, enhancing the visibility and reach of their work citeturn0search0.Recent Highlights
The journal consistently features groundbreaking research, such as:- Studies on fasting-mimicking diets enhancing the efficacy of CDK4/6 inhibitors in breast cancer
- Investigations into autophagy's role in immunotherapy resistance in KRAS-mutated pancreatic cancer
- Development of zebrafish patient-derived xenograft models to predict carboplatin resistance in ovarian cancer
Journal Metrics
RankingQ1
Impact Factor15.8
H-index148
SJR5.279
Research Score2.1
Coverage1998-2026
ISSN13687646, 15322084
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Sure! Here's a 500-word, SEO-friendly piece of content on the scope of drug resistance updates:Scope of Drug Resistance Updates: A Vital Resource for the Global Health Community Drug resistance has emerged as one of the most pressing public health threats of the 21st century. As bacteria, viruses, parasites, and fungi continue to evolve mechanisms to evade the effects of therapeutic agents, healthcare systems worldwide face growing challenges in treating once-manageable diseases. The journal Drug Resistance Updates plays a critical role in the fight against antimicrobial resistance (AMR), providing comprehensive and cutting-edge insights into the mechanisms, epidemiology, and strategies for combating drug-resistant pathogens.
What Is Drug Resistance Updates?
Drug Resistance Updates is a peer-reviewed scientific journal that serves as an authoritative resource for researchers, clinicians, and public health professionals. Its primary mission is to publish high-impact review articles and research updates that explore the rapidly evolving landscape of drug resistance. Topics covered include molecular mechanisms of resistance, clinical implications, surveillance data, novel therapeutic strategies, and public health policies.Scope and Coverage
The scope of Drug Resistance Updates spans a broad range of disciplines within microbiology, pharmacology, and clinical medicine. Key areas of focus include:- Antibiotic Resistance: In-depth reviews on resistance mechanisms in gram-positive and gram-negative bacteria, including MRSA, CRE, and drug-resistant Mycobacterium tuberculosis.
- Antiviral Resistance: Coverage of resistance patterns in HIV, hepatitis viruses, influenza, and emerging viral threats such as SARS-CoV-2.
- Antifungal Resistance: Updates on resistance in Candida, Aspergillus, and other clinically significant fungi.
- Antiparasitic Resistance: Focus on malaria, leishmaniasis, and other parasitic infections where resistance is impacting treatment efficacy.
- New Drug Development: Reviews of novel antibiotics, antivirals, and antifungals, including drug repurposing and next-generation therapies.
- Mechanistic Studies: Insights into genetic, biochemical, and cellular pathways leading to resistance.
- Epidemiology and Surveillance: Global trends and data on resistance outbreaks and regional patterns.
- Public Health and Policy: Discussions on antimicrobial stewardship, infection control, and strategies to slow resistance development.
Why It Matters
As resistance grows, treatment options narrow, leading to longer hospital stays, higher medical costs, and increased mortality. Staying updated on the latest research and developments is crucial for healthcare professionals and policy-makers. Drug Resistance Updates offers a centralized, credible source of information that facilitates evidence-based decision-making and fosters global collaboration.SEO Keywords to Note
To enhance online visibility and relevance, this content integrates key SEO terms, including:- Drug resistance
- Antimicrobial resistance (AMR)
- Antibiotic resistance updates
- Drug Resistance Updates journal
- Mechanisms of resistance
- Emerging infectious diseases
- Novel antimicrobial therapies
Final Thoughts
With the growing burden of drug resistance worldwide, Drug Resistance Updates stands out as a premier resource offering timely, scientifically rigorous content. Its broad scope and multidisciplinary approach make it indispensable for anyone involved in the fight against infectious diseases. Regular engagement with this journal helps the scientific and medical community stay one step ahead in the ongoing battle against resistant pathogens.Recent Research Articles
Latest publications matched automatically by ISSN.
No recent articles could be verified for this ISSN.
Reviews
Community Reviews
No approved community reviews yet. Be the first to contribute a verified experience.
Write a ReviewVersion History
Profile last updated
April 21, 2025 at 8:08 am
Profile published
April 21, 2025